| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pres. Research &Development | President &CEO | Chief Executive Officer
1 company
Young David is a Pres. Research &Development at Processa Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 9 buys and 0 sells.
Estimated insider holdings value: $608K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2025 | PCSA Processa Pharmaceuticals, Inc. | Pres. Research &Development | Buy | 124,500 | $0.80 | $99,288.75 | +153.9% | -61.5% | -79.1% | |
| Feb 7, 2024 | PCSA Processa Pharmaceuticals, Inc. | Pres. Research &Development | Buy | 21,000 | $2.45 | $51,525.60 | +36.0% | +11.2% | -73.3% | |
| Feb 6, 2024 | PCSA Processa Pharmaceuticals, Inc. | Pres. Research &Development | Buy | 20,000 | $2.53 | $50,504.00 | +52.1% | -1.3% | -74.8% | |
| Jun 12, 2023 | PCSA Processa Pharmaceuticals, Inc. | President &CEO | Buy | 40,000 | $0.80 | $32,000.00 | +9.3% | -60.3% | -87.7% | |
| Apr 14, 2023 | PCSA Processa Pharmaceuticals, Inc. | President &CEO | Buy | 20,000 | $0.55 | $10,998.00 | +4.9% | -2.5% | -83.3% | |
| Apr 13, 2023 | PCSA Processa Pharmaceuticals, Inc. | President &CEO | Buy | 60,000 | $0.48 | $29,000.00 | +5.4% | +6.3% | -82.2% | |
| Jun 23, 2021 | PCSA Processa Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 10,000 | $7.67 | $76,716.00 | +3.0% | -4.1% | -61.8% |